The Effects of Proprioceptive Neuromuscular Facilitation

NCT ID: NCT07344272

Last Updated: 2026-01-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-02-01

Study Completion Date

2026-03-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to investigate the effects of proprioceptive neuromuscular facilitation (PNF) on shoulder girdle function and quality of life in individuals with scapular winging.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Scapular stability on the thorax is fundamental for maintaining proper upper extremity function. The loss of this stability manifests clinically as scapular winging, a pathological condition characterized by the prominent protrusion of the medial (vertebral) border and/or the inferior angle of the scapula away from the thorax.

PNF can target the underlying impairment of scapular dysfunction by activating the muscle synergies required for scapulothoracic stability more powerfully and coordinately through resisted diagonal movements.

Therefore, the implementation and testing of PNF protocols are of critical importance, as this method can enhance functional strength and coordination, contributing to better clinical outcomes and improved quality of life in individuals with scapular winging.

Therefore, this study aims to investigate the effects of PNF on shoulder girdle function and quality of life in individuals with scapular winging.

In this study, designed as a randomized controlled trial, one group will receive PNF in scapular diagonals for approximately 20-30 minutes, three days a week, for a total of five weeks, to ensure scapular positioning and increase the tone of the surrounding muscles.

The control group will receive no intervention during this period.

Before (pre-test) and after (post-test) the study, participants in both groups will be evaluated using the Scapular Isometric Pinch Test for scapular muscle endurance; the Lateral Scapular Slide Test for scapular position; the Rounded Shoulder Posture Assessment for shoulder posture; the Disabilities of the Arm, Shoulder, and Hand Questionnaire for upper extremity functional level; and the Short Form-36 for quality of life.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Scapular Winging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This study will be conducted as a randomized controlled trial. Participants will be randomly assigned to two groups: the intervention group (proprioceptive neuromuscular facilitation intervention) and the control group (no intervention).
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors
The intervention group will receive proprioceptive neuromuscular facilitation and outcome measures will be assessed by an investigator who was blinded to the group allocation.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Proprioceptive Neuromuscular Facilitation Group

The Proprioceptive Neuromuscular Facilitation Group will receive proprioceptive neuromuscular facilitation for a duration of 5 weeks, scheduled three times per week, with a session length of approximately 20-30 minutes.

Group Type ACTIVE_COMPARATOR

Proprioceptive neuromuscular facilitation

Intervention Type OTHER

The Proprioceptive Neuromuscular Facilitation Group will receive proprioceptive neuromuscular facilitation for a duration of 5 weeks, scheduled three times per week, with a session length of approximately 20-30 minutes.

Control Group

The Control Group will receive no intervention.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Proprioceptive neuromuscular facilitation

The Proprioceptive Neuromuscular Facilitation Group will receive proprioceptive neuromuscular facilitation for a duration of 5 weeks, scheduled three times per week, with a session length of approximately 20-30 minutes.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Volunteering to participate in the study.
* Presenting with bilateral scapular winging (Scapular winging will be evaluated by measuring the distance between the inferior angle of the scapula and the thoracic wall using a scapulometer; a distance of ≥2 cm is considered as winging).

Exclusion Criteria

* Presence of long thoracic nerve palsy.
* Having undergone shoulder surgery within the last 12 months or having an acute shoulder injury (e.g., rotator cuff tear, dislocation, labral pathology, etc.).
* Presence of scapulothoracic bursitis, fractures, tumors, or structural deformities in the scapular/thoracic region.
* Having received regular scapular or shoulder rehabilitation within the last 6 months.
Minimum Eligible Age

20 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Celal Bayar University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Erhan Seçer

Lecturer, PT., PhD.

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CBU-FTR-ES-O7

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pilates to Treat Neck Pain
NCT02433821 COMPLETED PHASE3